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ABSTRACT 
Differentiated somatic cells can be reprogrammed into induced pluripotent stem cells (iPS cells) by introducing 
specific transcription factors. This technique avoids immune rejection and ethical problems in stem cell research. 
A great revolution in the fi eld of science. As with embryonic stem cells (ES cells), iPS cells are able to self-renew 
and maintain undiff erentiated state. In vitro, iPS cells can be induced to diff erentiate into a variety of mature cells, 
therefore, iPS cells in theoretical research and clinical applications are extremely valuable. IPS cell diff erentiation 
and transplantation in the treatment of blood diseases have a great use, iPS cells can treat nervous system diseases, 
to provide in vitro disease model, to study the mechanism of disease formation, screening new drugs and the 
development of new to provide a new treatment The The use of iPS cells as a nuclear donor cell, with the appropriate 
receptor cells after fusion can be directly obtained transgenic animals. Not only can improve the genetic nature of 
animals, but also can break the boundaries of species and get the new animal traits that cannot achieve by using 
traditional mating methods. The research of iPS cells has been widely concerned, and it is the research hotspot in cell 
biology and molecular biology. In this paper, the defi nition of iPS cells, the acquisition of iPS cells, the history of 
development, the signifi cance of research, the progress of research, the application of iPS cells, and the problems of 
iPS cells were reviewed.
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1. Preface
1.1. Overview of iPS cells
IPS cells reproduce diff erentiated somatic cells into induced pluripotent stem cells (iPS cells) by introducing specifi c 
transcription factors. Specifi c transcription factors are Oct4, Sox2, c-Myc and Klf4 4 factors (these four factors, also 
known as Yamanaka factor) can eff ectively convert fetal mouse embryonic cells (mouse embryonic fi broblast, MEF 
cells) and mouse tail fi broblasts induce morphogenesis and growth characteristics similar to ES cell clones, iPS cells. 
IPS cells also allow common somatic cells to ‘initialize’ to make them stem cell function. ‘IPS cells’ have similar 
functions to embryonic stem cells, and without the need to make embryos, cells from stem cells can be produced 
from cells of any tissue or even skin cells. IPS cells and embryonic stem cells can produce all the cells in addition to 
the embryos, and if they are used for medical treatment, theoretically can cure all the diseases - all the bad tissues are 
removed and replaced with the normal tissue that grows.
1.2. Study the signifi cance of iPS cells
Successful establishment of iPS cells, the application of iPS cells to treat disease is the ultimate goal of people. IPS 
cells can be used not only for diff erentiation and transplantation, but also to provide in vitro disease models to facilitate 
the study of disease formation mechanisms, screening new drugs and developing new treatments. The establishment 
of human iPS cells is recognized as one of the most important advances in science and technology in 2007. This 
technology not only establishes individual pluripotent stem cell lines from somatic cells, but also addresses the problem 
of immune rejection in cell transplantation therapy. The mechanism of cell reprogramming, and the mechanism of 
individual-specifi c disease pathogenesis provide a powerful approach. In the fi eld of stem cell research, the emergence 
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of iPS cell technology is undoubtedly a landmark breakthrough, a variety of somatic cells in vitro culture and induction 
can be transformed into a multi-directional diff erentiation of stem cells, and proved that several known transcription 
factors can diff erentiate and reverse the somatic cells to undiff erentiated state, indicating the huge plasticity of cells.
2. Advances in iPS Cell Research
2.1. Establishment of iPS cells
Somatic cell nuclear transfer or cell fusion can reprogram highly diff erentiated somatic cells, cell reprogramming 
refers to the process of transitioning mature cells from a differentiated state to an undifferentiated state [3]. Studies 
have shown that mouse embryos are early in 2-cell stage to 4-cell stage, each blastomere is likely to have shown a 
diff erent developmental tendencies [4]. After that, the cells are constantly diverging in diff erent directions. Regardless 
of the extent of cell diff erentiation, they are identical to undiff erentiated cells in their genetic makeup. However, in their 
development process, their genomes have undergone many epigenetic modifi cations, indicating that in the oocytes and 
ES cells may contain some factors that can start cell reprogramming, can induce somatic cell epigenetic changes and re-
change acquired developmental pluripotency, like re-initiation of fertility as fertilized eggs.
2.1.1 Four factors
So, can direct application of the relevant transcription factors on the somatic cell reprogramming and reverse the 
development potential of undiff erentiated cells, and thus show the ES cells as much potential? Takahashi and Yamanaka 
[4] selected 24 transcription factors that were abundantly expressed in mouse early embryonic ES cells or tumor cells. 
By screening and combining, we found Oct4, Sox2, c-Myc and Klf4 4 factors (these four factors Also known as the 
Yamanaka factor) can effectively induce fetal mouse fibroblasts (MEF cells) and mouse tail tip fibroblasts to form 
morphological and growth characteristics similar to ES cell clones, iPS cells. Moreover, these iPS cells express ES cell-
specifi c marker genes.
Why is the introduction of only a few factors that can induce somatic cells to reprogram and have plurality? 
According to the results of the current research, it can be seen that the pluripotency of ES cells is regulated by the 
transcription factor network and epigenetics, but in fact, the expression of several genes can induce pluripotent 
somatic cells. The effects of Oct4/Sox2/Klf4/Klf4/c-Myc and Oct4/Sox2/Nanog/Lin28 on pluripotency regulation 
were introduced in this paper. The key role of Oct4, Sox2 and Nanog transcription factors which were used in ES cells, 
played by the maintenance of sex has been well known. Oct4 is a vital factor in pluripotency regulation, and Oct4 
is absent, and ES cells are not available at all. To maintain pluripotency, Oct4 expression levels must also be strictly 
controlled [6], Oct4 defi cient or excessive ES cell diff erentiation. Oct4 regulates many genes in need of synergism with 
Sox2. Sox2 expression is not limited to pluripotent cells, but it is also important for early embryonic development and 
inhibition of diff erentiation. The lack of Sox2 embryos cannot form epiblast, which blocks the function of Sox2 in ES 
cells diff erentiation [6]. Nonog transcription is regulated by Oct4 and Sox2 [7], and its absence will lead to spontaneous 
differentiation of cells into primordial endodermal cells [8]. Genome-wide analysis revealed that Oct4, Sox2 and 
Nanog co-control a number of target genes in mouse and human ES cells, in which many of the gene products are 
important transcription factors for development. Oct4, Sox2 and Nanog transcription factors together to form the ES 
cell regulation system, which involves self-regulation and feed forward and other mechanisms. C-myc is a well-known 
proto-oncogene that plays a role in the self-renewal of certain adult stem cells. C-myc is a major downstream gene of 
the Lif/STAT3 and Wnt signaling pathways [9], both of which are important for the maintenance of pluripotency. Klf4 
has the dual character of oncogene and tumor suppressor genes [10]. Its overexpression can maintain the expression of 
Oct4 and inhibit the diff erentiation of ES cells [11]; it can coordinate Oct4 and Sox2, thereby regulating the transcription 
of certain genes [12]. Lin28 is a negative regulatory gene that controls the development of many cells in many species 
[13]. In human and mouse ES cells, the expression of Lin28 decreased with the diff erentiation of ES cells.
2.1.2 Optimization of the system
The early establishment of iPS cells was performed by using retrovirus-mediated expression of four Yamanaka 
factors, followed by culturing the cells in ES cell culture medium and screening for the activation of pluripotency-
related promoters with resistance genes such as Oct4 and Nanog promoter, and the pluripotency of iPS cells was 
identifi ed after obtaining iPS cells with similar cell morphology.
These methods are very ineffi  cient to construct iPS cells [14], cell pluripotency, and have inherent safety problems, 
such as viral insertion of mutations in c-Myc carcinogenicity, making it still unusable for clinical treatment. In order to 
solve these safety problems and improve the effi  ciency of iPS cell system, people have improved the construction of iPS 
cells in many ways.
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2.1.2.1 Transposon technology
British and Canadian scientists did not use viral vectors for the first time to develop safer induction of 
multifunctional dry (iPS cells) [15]. Their research work is based on a method developed by the Kyoto University 
scientist in the mountains, two years ago. Yamamoto and his colleagues implanted four genes into skin cells and were 
induced into pluripotent stem cells, making a major breakthrough in stem cell research. However, the vector used for 
their transplantation is a retrovirus, which means that this approach may increase the risk of cancer in patients using iPS 
cells. In order to avoid this technical fl aw, the British and Canadian scientists used the transgenic crop commonly used 
‘transposon’ technology, which can be called ‘transposon’ gene sequence inserted into the target genome. Researchers 
have experimented with skin cells from mice and humans, and the results show that the recombinant cell lines are fully 
characterized by embryonic stem cells [16].
2.1.2.2 Reduce the risk of cancer
Japanese scientists have only two transplanted genes to cultivate human induced pluripotent stem cells (iPS cells), 
Japan’s Gyeongbuk University Professor Okano’s research team, only used to cultivate iPS cells used in the four 
induction genes in two, which are ‘0ct3/4’ gene and ‘Klf4k’ gene, also successfully cultivated iPS cells. Because in 
addition to the use of retrovirus as a vector for gene transplantation, the factors that cause the risk of cancer in iPS cells 
are also associated with a gene called ‘c-Myc’ in the four induction genes used by previous researchers related. So, the 
latest Japanese scientists can also reduce the risk of cancer after iPS cell transplantation.
2.1.2.3 Effi  cient and rapid establishment of iPS cells
Our scientists quickly establish human iPS cells from amniotic cells. Our scientists have made signifi cant progress 
in the fi eld of iPS cell research after the fi rst time in the world for the fi rst time in mice that have been developed by 
the induction of pluripotent stem cells (example: iPS cells) [18]. For the fi rst time, rapid establishment of iPS cells, 
the time required only 6 days, for the current human iPS cell related reports in the shortest. Recently published in the 
international authority of the magazine ‘Human Molecular Genetics Journal’ on the results of this is by the Chinese 
Academy of Sciences Shanghai Academy of Life Sciences/Shanghai Jiaotong University School of Medicine Institute 
of Health Science Jin Ying researcher led the stem cell research group and Shanghai Xinhua Hospital Professor Chen 
Fang Cooperation done. According to a researcher introduced by Jin Ying [19], scientists have succeeded in inducing 
somatic cells of mice, rats, macaques, pigs and humans into iPS cells, and induction techniques have also undergone 
significant innovations such as reducing the number of exogenous transcription factors. The use of non-integrated 
virus, plasmid method and so on. “At present, the study of human-induced pluripotent stem cells is still in its infancy, 
and the donor cells are only confi ned to a small number of cell types such as human foreskin fi broblasts, epidermal 
cells and hair follicle cells. The reason to make these become more troublesome is the time required to reprogram the 
iPS cells is relatively long (usually 16 to 35 days) and the effi  ciency is low, which greatly increases the risk of cell 
variation in the process.” Kim said, “So, the topic of how do you fi nd an ideal human somatic cell source, is the focus 
of the world’s scientists focus on the subject.” According to reports, Dr. Li Chunliang doctoral researcher under the 
guidance of Jin Ying, pregnant women from prenatal diagnosis of the remaining amniotic cells found in a special group 
[20]. They were genetically induced by four factors induced by virus, the morphological changes were observed on the 
second day after infection, and the clones of human embryonic stem cells were similar on the fourth day. Researchers 
on the establishment of eight human induced pluripotent stem cells for further identifi cation and found that these cells 
can be long-term stable in vitro and in vitro long-term passaged karyotype normal, maintain self-renewal, protein and 
transcription levels of high expression of pluripotent marker gene. The main application of induction of pluripotent stem 
cells is diff erentiation and cell transplantation. Researchers in accordance with international standards to try the amniotic 
fl uid-derived iPS cells in vitro and in vivo diff erentiation potential, the results found that iPS cells can be divided into 
neurotropic cells, including a variety of human cells.
2.1.3 To improve the effi  ciency of iPS cell preparation
2.1.3.1 Blocking of genes
Since the discovery of iPS cells, scientists have successfully introduced multiple somatic cells into iPS cells 
by introducing transcription factors, but the low induction efficiency has been a major obstacle to iPS technology. 
Transcription factor c-Myc is a proto-oncogene, people try to remove this gene to reduce carcinogenicity, however, 
c-Myc removal of carcinogenicity, although reduced, the induction effi  ciency is even lower. In September 2009, Hong 
et al. found that the removal of c-Myc after the gene with siRNA blocking a gene called p53, can be skin cells into iPS 
cells, the success rate increased to about 10%, about the original conversion rate of 100 times. Studies have shown that 
p53 is a regulator of cellular procedures and the key factor of rearrangement, which relates to the level of conversion 
efficiency. DNA chip analysis showed that there were 34 genes involved in p53 regulation in mouse and human 
Research Progress and Application Prospect of IPS Cells
4
fi broblasts, and the functional analysis of these genes showed that, blocking the p53-p21 pathway not only improves the 
effi  ciency of iPS cell transformation but also reduces the carcinogenicity of iPS. More importantly, the silence of p53 
gene can be used not only for viral vector induction technology, but also for plasmid or protein-induced transformation 
of the technology is also feasible.
2.1.3.2 Synergies
Peking University Professor Deng Hongkui in the induction of human iPS cells, screening a series of related genes 
and found that p53 gene interference small RNA and gene can be synergistic eff ect, the iPS cell induction effi  ciency 
increased nearly 100 times, even without proto-oncogene C-Myc, can also effi  ciently and stably induce the formation of 
human iPS cells.
2.1.3.3 Induction of adipose-derived stem cells
In September 2009, Stanford University researchers, Sun et al., found that Humanadipose stem cells (hASCs) were 
more likely to be induced as iPS cells than skin fi broblasts, and that iPS cells were safer. They found that in adipose-
derived stem cells and skin fibroblasts, respectively, to be able to encode four transcription factors after the gene, 
about one in ten of the skin fi broblasts into iPS cells, and the ratio of adipose-derived stem cells transformed into iPS 
cells reached 2%, is the former 20 times. Four transcription factors (Oct4, Sox2, Klf4 and c-Myc) involved in the 
induction of iPS cells were not substantially expressed or expressed in skin fi broblasts. The expression levels of two 
transcription factors in adipose-derived stem cells are higher than those of dermal fi broblasts, suggesting that adipose-
derived stem cells are more likely to be induced in the initial state. Induced by adipose - derived stem cells of iPS cells 
can be diff erentiated into the human body of nerve cells, muscle cells and intestinal epithelial cells. In addition, the use 
of adipose stem cell culture iPS cells do not need to raise cells, which undoubtedly improve its safety. Because hASCs 
provide a better somatic cell source for iPS cells, when appropriate, when iPS cells are used in clinical treatment, 
appropriate donor cell types can be selected, which ensures high induction effi  ciency and improves the safety of iPS 
cells.
2.1.3.4 iPS cells induce oxygen in the environment
The oxygen concentration of the culture environment also has an eff ect on the induction effi  ciency of iPS cells [22]. 
Yamanaka et al. found that stem cells in the body were always concentrated in places where oxygen was relatively 
small, and they reduced the oxygen concentration of the culture environment from 21% to 5% when iPS cells were 
cultured with human skin cells and found that iPS cells generating effi  ciency can be increased to the original 2.5 times 
to 4.2 times. But if further reduce the oxygen concentration to 1%, it will be counterproductive part of the cell death. 
Inducing mouse skin cells, it is also possible to verify that the 5% oxygen concentration is most appropriate. Thus, they 
believe that higher quality iPS cells can be efficiently obtained by reducing the oxygen concentration in the culture 
environment and using a culture method with less cell carcinogenesis. In October 2009, the research team led by Dr. 
Ding Sheng, a researcher at the Scripps Institute in the United States, focused on the study of the transformation of the 
fi brous cells that produce connective tissue fi broblasts. The combination of chemical substances is the most eff ective in 
promoting the transformation of fi broblasts into stem cells, which is 100 times more effi  cient than traditional methods. 
Subsequently, the researchers also locked a new compound called Thiazovivi, this compound with SB43142 and 
PD0325901 in combination, can improve the effi  ciency of 200 times, while the transformation cycle from the original to 
4 weeks shortened to 2 weeks.
2.1.3.5 Eff ect of additives
December 2009, the Chinese Academy of Sciences, Guangzhou Institute of Biomedical and Health Pei Duanqing led 
the research team another way, the research direction into the extracellular environment of a medium composition, by 
adding vitamin C in the culture process can increase iPS induction effi  ciency 10 times, and through mouse and human 
cell experiments found that the culture of vitamin C can promote the expression of related genes to promote somatic 
cells into the reprogrammed state. They used careful experimental design to prove that external factors play an important 
role in iPS. In addition, Harvard University researchers also found that the addition of specifi c compounds can increase 
the effi  ciency of somatic cell-induced iPS by more than 100 times. In the induction process, they used four kinds of 
genetic genes, and added seven kinds of compounds that could hinder the synthesis of specifi c proteins. The results 
showed that the introduction effi  ciency of the genes was 0.01% – 0.05% without the addition of the compounds. After 
adding a protein called ‘Balpric acid’ protein synthesis inhibitor, the introduction of effi  ciency rose to 9.6% to 14%. 
At the same time, the latest report also found that butyrate treatment can signifi cantly improve human iPS induction 
effi  ciency.
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2.2. Application of iPS cells
2.2.1 iPS cells in the treatment of blood diseases
Xu et al [1] induced iPS cells into endothelial progenitor cells, and then transplanted into the liver with hemophilia 
mice, so that the symptoms of bleeding more than the disease has been eff ectively improved. Hanna et al. reprogrammed 
the diseased mouse mandibular fibroblasts into iPS cells then replaced the pass globin gene with the human wild p 
A. globin gene by homologous recombination, followed by the genetically modified iPS cells then differentiation 
into hematopoietic progenitor cells (HPs), and the purified HPs were transplanted into hps/llps male mice, and Has 
eff ectively inhibited the symptoms of sickle red blood cell anemia. Japan has made platelets with human iPS cells. The 
professor of stem cell biology at the University of Tokyo, Japan, recently succeeded in culturing platelets with human 
induced pluripotent stem cells (iPS cells), which is the fi rst time in the world. Chinese and other researchers and the use 
of Japanese University of Kyoto professor in the same way. The human skin cells were implanted into the iPS cells. In 
the development of iPS cells, the researchers added human bone marrow cells and cells to promote cell proliferation 
and other substances results iPS cells into platelet progeny megakaryocytes; after megakaryocytes further diff erentiation 
into platelets. Platelets are one of the important components of mammalian blood, with contraction of blood vessels, the 
formation of thrombosis, to help stop bleeding and other functions. The platelets used in the surgery are now collected 
mainly by blood donation, in which case the platelets can only be stored for a few days and are very inconvenient. 
The researchers said, the results of this study also show that, technically speaking, it is possible to cultivate human 
erythrocytes and leukocytes with iPS cells.
2.2.2 Promote the mechanism of tumor
First, genetic abnormalities accumulate epigenetic abnormalities are important factors for tumorigenesis and 
progression. The normal cells that carry the tumor susceptibility gene or have a genetic background with tumor 
orientation were reprogrammed into iPS cells [24], induced to differentiate into cells of a specific tissue type, and 
the presence of the tumor was observed in a culture dish to identify key tumors Inhibitory factors and factors of 
environmental formation.
Second, the results of nuclear transplantation techniques have shown that reprogramming the tumor cells themselves 
as stem cells is quite difficult, that is, tumor cells are resistant to reprogramming, and that the emergence of iPS 
technology brings hope for this operation.
Third, the tumor cells have a specifi c genetic background, if they can be re-programmed by the iPS technology for 
stem cells, will remove the tumor-specifi c epigenetic state, by induction of diff erentiation into the normal phenotype of 
cells, the relationship between epigenetic changes and tumorigenesis under the background of genetics.
Fourth, in recent years, an important breakthrough in the field of tumor research is the identification and 
identifi cation of cancer stem cells, but still cannot be effi  cient and high purity of tumor stem cells in vitro expansion and 
long-term culture, thus hindering the tumor stem cell biology unique characteristics of the analysis, and the development 
of therapeutic research for cancer stem cells is slow, if the iPS technology can be divided into short-lived state of tumor 
cells reprogrammed into tumor stem cells, will give the field of cancer research has brought great opportunities for 
development.
2.2.3 Somatic cell nuclear transfer technology
The use of iPS cells as a nuclear donor cell, with the appropriate receptor cells after fusion can be directly obtained 
transgenic animals. Therefore, the combination of iPS cell induction technology and animal transgenic technology 
not only can improve the genetic nature of animals, but also can break the boundaries of species, access to traditional 
mating methods cannot get the new animal traits. In 2010, two research teams in China established the pig’s iPS cell 
line for the fi rst time in the world, fi lling the gap between mice and humans. The research team from Pei Duanqing, 
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences isolated the fibroblasts from the 
embryos of the Tibetan miniature pig and introduced the transcription factor into the fi broblasts by retrovirus, which 
successfully induced the iPS cell line 11. ‘The study group of Shanghai Institute of Biochemistry and Cell Biology, 
Chinese Academy of Sciences was able to successfully reprogram the porcine adult cells into pluripotent stem cells 
using the expression vector of the lentiviral expression system (Tet-on/of system), which was further screened and 
identifi ed and fi nally obtained to meet the pluripotent stem cells Standard pig iPS cell line 11. This is the fi rst time in the 
world to produce domesticated ungulate animal pluripotent stem cells. Pigs are physically diff erent from humans, so the 
establishment of pig iPS cells is of great signifi cance:
First, we can use the induction of stem cells to modify the pig’s immune-related genes, so that the pig’s organs are 
compatible with the human immune system;
Second, many human diseases are caused by gene expression disorders, and we can modify the genes of pigs in 
Research Progress and Application Prospect of IPS Cells
6
stem cells and develop pigs carrying the same genetic barriers and then use this pig model to develop a method of 
treating the disease;
Third, the use of iPS technology to produce an accurate transgenic pig, to improve its tolerance to a disease, thereby 
improving the animal husbandry. Recently, there is no such report in cattle, sheep and other large animals. If we can 
build iPS cells of these animals and apply them to produce gene targeting or transgenic animals, it is necessary to 
improve the effi  ciency of transgenic animals. To create a broader world.
3. Problems and Prospects
3.1. iPS cells face problems
After nearly fi ve years of long and short-term development, iPS cell technology has made remarkable progress. A 
breakthrough result has brought us joy, but also brought new challenges, cell reprogramming is expected to usher in a 
new wave of research. Although iPS cells have attractive application prospects, however, future iPS cell research is also 
faced with many urgent problems:
First, effi  ciency issues. At present, the rate of induction of iPS cells is still very low, which is related to the way 
genetic integration of the site, epigenetics and other factors. This has become the biggest bottleneck restricting iPS from 
laboratory to clinical. Therefore, how to improve the effi  ciency of iPS cell preparation is still a common concern.
Second, security issues. Now the induction of iPS cells is usually through the retrovirus as the carrier, several 
oncogenes into diff erentiated cells to induce it to become iPS cells, and this method may be due to foreign gene into the 
cell genome, interfere with the expression of endogenous genes, thus inducing cancer.
Third, the mechanism of the problem. The pluripotency of cells is regulated by the transcription factor network and 
epigenetics, and how do a few transcription factors rely on a complex task to induce pluripotent cells? It is also one of 
the important tasks to study the molecular mechanism, regulation mechanism and in vitro diff erentiation mechanism of 
somatic cell reprogramming.
3.2. Prospects for iPS cells
Since the birth of iPS cell technology, has been a great concern and extensive research, has now become the focus 
of research and discussion of life science research, iPS cells and ES cells compared to avoid immune rejection and 
ethical issues, has many advantages in the study of transgenic animals, iPS cells can act as transgenic target cells, 
which can transfer foreign genes into iPS cells by certain transgenic techniques, or genetic modifi cation of iPS cells for 
gene targeting or gene knockout. The willingness to achieve iPS intracellular gene transformation, effi  cient, targeted 
production of transgenic animals. Through the study of animal models, scholars have made the necessary supplement 
to the study of human diseases. Before the advent of iPS technology, it is hard to imagine an accurate observation 
of the pathology of some hereditary or degenerative diseases in petri dishes, and the emergence of iPS technology 
makes these no longer diffi  cult. Recently, Park et. al used iPS technology successfully established 10 kinds of human 
hereditary or degenerative disease origin of stem cell lines, including adenosine deaminase defi ciency associated with 
severe combined immunodefi ciency disease (ADA-SCID), Huntington’s disease (HD) , Parkinson’s disease (PD) and 
adolescents with type I diabetes (JDM). [23]. These disease-specifi c iPS cells carry the genetic defects of the disease 
itself, but can be eff ectively normalized to diff erentiate into a variety of cell types. These cell lines provide a material 
basis for the formation of normal and pathological tissues under in vitro conditions. In addition, it also provides a 
cellular model for the testing and screening of disease therapeutic drugs, providing unprecedented hope for basic 
research and clinical disease treatment.
In the view of the important role and potential of iPS in disease research, the Harvard University Stem Cell Research 
Institute launched a program to establish a disease-specifi c iPS cell bank in 2008, as well as the other four universities 
(Kyoto University, Gyeongye University, University of Tokyo and physicochemical Institute) established the iPS Cell 
Research Center. Facing with these rapid development, due to the large population of China, with extremely rich disease 
resources, for our unique disease population to establish disease-specifi c iPS cell pool should be mentioned as soon 
as possible on the agenda. Especially for some rare or unique hereditary diseases, preserving the cell seeds that can be 
studied for diff erentiation is far more valuable than preserving DNA.
The establishment of human iPS cells is recognized as one of the most important advances in science and technology 
in 2007. This technology not only establishes individual pluripotent stem cell lines from somatic cells, but also 
addresses the problem of immune rejection in cell transplantation therapy. The mechanism of cell reprogramming, 
and the mechanism of individual-specifi c disease pathogenesis provide a powerful approach. In the fi eld of stem cell 
research, the emergence of iPS cell technology is undoubtedly a landmark breakthrough, a variety of somatic cells in 
-7
vitro culture and induction can be transformed into a multi-directional diff erentiation of stem cells, and proved that 
several known transcription factors can diff erentiate somatic cells and reverse to undiff erentiated state, indicating the 
huge plasticity of cells. IPS technology expand the horizons and imagination of human beings, the researchers consider 
that without the iPS stage, the use of transgenic or non-transgenic approach to a source of convenient somatic cells 
directly reprogrammed into another somatic cells, to be used directly in the treatment of human diseases. In vivo studies 
have shown that pancreatic exocrine cells can be directly reprogrammed into endocrine cells by introduction of specifi c 
transcription factors. In addition, there are similar biological processes in the regeneration of many lower animal 
tissues or organ injuries. Therefore, continue to focus on and study the theory and key technologies of iPS, will give the 
development of normal development model, tumor research, tissue repair and regeneration and bio-pharmaceutical and 
many other biomedical fi elds to bring new opportunities for development.
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